Ankylosing spondylitis
More regulation of total hip replacement devices needed to prevent unnecessary surgery in the UK
Experts are calling for greater UK compulsory regulation of devices used in hip replacements to reduce the need for further traumatic and expensive surgery following a study published in the British Medical Journal.
A team from Warwick Medical School looked at five of the most commonly used hip replacement devices and assessed how many had to be replaced within 10 years of the original surgery. Continue reading
Era of biosimilar drugs – what impact for people with arthritis?
With patents for some key arthritis drugs reaching the end of their lifespan, biosimilars – biological medicine made to be similar to an existing biological medicine – will be used more widely as a cheaper option for the NHS. But what does this actually mean for people with rheumatoid arthritis and ankylosing spondylitis. Continue reading
Paracetamol: long-term risks may be underestimated says new review
The long-term health risks that could be associated with the commonly-taken painkiller paracetamol need to be reassessed, says a group led by Prof Philip Conaghan of the Leeds Institute of Rheumatic and Musculoskeletal Medicine. Continue reading
Ankylosing spondylitis and spondyloarthritis: DMARDs can improve anti-TNF retention rates
We know that sticking to prescribed medication is important because failure to do so reduces its effectiveness and may lead to a worsening of disease. But a recent study revealed that almost 30% of people with rheumatoid arthritis on biologic therapies such as anti-TNF do not take their medication as prescribed.
Now new research highlights that people Continue reading
Cheaper therapy for rheumatoid arthritis and ankylosing spondylitis now available in UK
An affordable new anti-TNF therapy for the treatment of rheumatoid arthritis has been launched in the UK. The new therapy – Remsima – can also be used for ankylosing spondylitis, Crohn’s disease, ulcerative colitis and psoriasis. Continue reading
